Creative Financing Approaches in Life Science
By Andrew Levitch, Mark Murray, Patrick Nugent, Linda Rubinstein
This article is the third in a 4-part series reviewing financing solutions for the Life Science sector. As Life Science company valuations have fluctuated significantly over the last two years, and investors have become cautious due to economic turbulence and market uncertainty, fundraising is taking longer. Equity financing has been…Read More
Read MoreYour Board Says Your Company Needs to be Restructured – Now What?
By Mark Archer
Corporate restructuring is the process of reorganizing a company’s management, finances, and operations to improve the efficiency and effectiveness of the company and increase shareholder value. These changes can also help a business increase productivity, improve the quality of products and services, and reduce costs. The overall goal of restructuring…Read More
Read MorePlanning a Medical Device Business is Not for the Faint of Heart
By Greg Johnstone
Creating a business plan for a medical device company is a complex challenge, even for the most experienced founder and management team. A medical device business must contend with many of the same issues that face other technology-driven businesses. These include difficult engineering challenges, fundamental physical or biological constraints, complex…Read More
Read MoreManaging CFO Relationships with Third Parties: Auditors, Bankers, Insurers, Lawyers, and Investors
By Ron Fior
NOTE: This is the third article in a series from Ron Fior about how CFOs can better manage relationships with CEOs, boards, finance teams, and third parties. CFOs are often asked to both vet and select third party consultants when working on key strategic initiatives that range from financings, M&A…Read More
Read More